HighTower Advisors
EHC icon

HighTower Advisors’s Encompass Health EHC Stock Holding History

HighTower Advisors’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Sell
17,173
-65
-0.4% -$6.67K ﹤0.01% 1831
2025
Q4 		$1.83M Buy
17,238
+450
+3% +$52.2K ﹤0.01% 1720
2025
Q3 		$2.13M Sell
16,788
-2
-0% -$238 ﹤0.01% 1593
2025
Q2 		$2.06M Sell
16,790
-2,155
-11% -$246K ﹤0.01% 1546
2025
Q1 		$1.92M Sell
18,945
-10
-0.1% -$976 ﹤0.01% 1549
2024
Q4 		$1.75M Buy
18,955
+1,764
+10% +$173K ﹤0.01% 1604
2024
Q3 		$1.66M Sell
17,191
-1,160
-6% -$104K ﹤0.01% 1621
2024
Q2 		$1.59M Buy
18,351
+944
+5% +$79.2K ﹤0.01% 1576
2024
Q1 		$1.44M Buy
17,407
+943
+6% +$69.1K ﹤0.01% 1594
2023
Q4 		$1.1M Buy
16,464
+2,673
+19% +$173K ﹤0.01% 1797
2023
Q3 		$930K Buy
13,791
+2,983
+28% +$205K ﹤0.01% 1821
2023
Q2 		$740K Buy
10,808
+3,954
+58% +$248K ﹤0.01% 1934
2023
Q1 		$370K Sell
6,854
-286
-4% -$16.6K ﹤0.01% 2304
2022
Q4 		$436K Buy
+7,140
New +$388K ﹤0.01% 2210
2022
Q3 		– Sell
-4,745
Closed -$212K – 3212
2022
Q2 		$212K Buy
4,745
+352
+8% +$18.1K ﹤0.01% 2600
2022
Q1 		$248K Buy
4,393
+161
+4% +$8.41K ﹤0.01% 2667
2021
Q4 		$220K Sell
4,232
-616
-13% -$31.8K ﹤0.01% 2689
2021
Q3 		$290K Buy
4,848
+760
+19% +$47.8K ﹤0.01% 2430
2021
Q2 		$253K Sell
4,088
-242
-6% -$16.1K ﹤0.01% 2489
2021
Q1 		$282K Sell
4,330
-165
-4% -$10.8K ﹤0.01% 2346
2020
Q4 		$294K Buy
+4,495
New +$264K ﹤0.01% 1943
2020
Q2 		– Sell
-4,131
Closed -$210K – 2454
2020
Q1 		$210K Buy
4,131
+471
+13% +$27.2K ﹤0.01% 1762
2019
Q4 		$201K Buy
+3,660
New +$199K ﹤0.01% 1973
2019
Q2 		– Sell
-9,401
Closed -$439K – 2417
2019
Q1 		$439K Buy
9,401
+569
+6% +$28.8K ﹤0.01% 1527
2018
Q4 		$431K Buy
8,832
+1,228
+16% +$69.8K ﹤0.01% 1432
2018
Q3 		$469K Buy
+7,604
New +$462K ﹤0.01% 1489

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

HighTower Advisors's EHC Position: Q1 2026 in Review

HighTower Advisors reduced its Encompass Health (EHC) stake by 0.38% in Q1 2026, selling an estimated $6.67K and leaving 17,173 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1831.

HighTower Advisors first reported a position in EHC in Q3 2018 and has held it in 26 quarters since. The position peaked at $2.13M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • HighTower Advisors held 17,173 shares of Encompass Health worth $1.66M as of Q1 2026.
  • HighTower Advisors sold 65 Encompass Health shares in Q1 2026, an estimated $6.67K.
  • Encompass Health made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #1831 holding.
  • HighTower Advisors first reported a position in Encompass Health in Q3 2018 and has held it in 26 quarters since.
  • HighTower Advisors's Encompass Health position peaked at $2.13M in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.